Related Experiment Video
Updated: Jun 10, 2025

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Association of Coronary Microvascular Rarefaction and Myocardial Fibrosis With Coronary Artery Disease
Duncan J Campbell1,2,3, Victoria C M Francis4,5, Gregory R Young4,5
1St. Vincent's Institute of Medical Research Fitzroy Victoria Australia.
Insights
Coronary artery disease (CAD) is linked to reduced coronary microvasculature and more myocardial fibrosis. These changes may explain increased risks of heart attack and heart failure in CAD patients.
Area of Science:
- Cardiovascular Pathology
- Microvascular Disease
- Cardiac Histology
Background:
- Coronary artery disease (CAD) affects millions globally.
- Understanding the impact of CAD on the heart's microvasculature and structure is crucial for patient outcomes.
Purpose of the Study:
- To investigate differences in coronary microvasculature and myocardial structure between individuals with and without CAD.
- To establish a histological basis for understanding CAD's progression and complications.
Main Methods:
- Autopsy samples of left ventricle free wall from 50 men and 48 women were analyzed.
- Participants were categorized into groups with significant CAD (≥75% stenosis) and without (minimal/no CAD), matched for age and sex.
- Histological analysis focused on arteriole density, capillary length density, and myocardial fibrosis.
Main Results:
- Individuals with CAD exhibited significantly higher heart weight compared to those without CAD.
- A notable decrease in arteriole density and capillary length density was observed in the CAD group.
- Increased total myocardial fibrosis was a significant finding in decedents with CAD.
Conclusions:
- Coronary artery disease is associated with coronary microvascular rarefaction (reduced density) and increased myocardial fibrosis.
- These microvascular and structural changes may contribute to the elevated risk of adverse cardiovascular events, including death, myocardial infarction, and heart failure.
- The observed changes may also influence the effectiveness of interventions like percutaneous coronary intervention in patients with stable angina.
Background:
To evaluate, in a cohort study, whether coronary microvasculature and myocardial structure differ between people with and without coronary artery disease (CAD).
Methods And Results:
We performed histological analysis of left ventricle free wall obtained at autopsy from 25 men and 23 women with ≥1 coronary artery with ≥75% area stenosis, and 25 men and 25 women without (no or minimal) CAD, matched for sex and age, who died suddenly from noncardiac causes. Decedents with myocardial infarction or other cardiac abnormality were excluded. Decedents with and without CAD had similar height and weight. Heart weight of decedents with CAD was higher than that of decedents without CAD (mean, 391 versus 364 g; mean difference, 27 g [95% CI, 0.3-54.0], P=0.048). Decedents with CAD had lower arteriole density (mean, 1.4 per mm2 versus 1.8 per mm2; mean difference, -0.4 per mm2 [95% CI, -0.6 to -0.2], P=0.0001), lower capillary length density (mean, 3164 versus 3701 mm/mm3; mean difference, -537 [95% CI, -787 to -286], P<0.0001), and higher total myocardial fibrosis (mean, 7.5% versus 5.7%; mean difference, 1.7% [95% CI, 1.0-2.5], P<0.0001), than decedents without CAD.
Conclusions:
CAD was associated with coronary microvascular rarefaction and increased myocardial fibrosis. The association of CAD with coronary microvascular rarefaction and increased myocardial fibrosis may contribute to the increased risks of death, myocardial infarction and heart failure that accompany CAD, and may attenuate the impact of percutaneous coronary intervention on cardiovascular risk in people with stable angina.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease I: Introduction
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations

